The standard treatment of advanced ovarian, fallopian tube and peritoneal cancer is cytoreductive surgery followed by platinum-based chemotherapy (du Bois et al., 2005). This type of cancer expands through the peritoneum, which is the thin and continuous epithelial layer covering the abdominopelvic cavity and abdominal organs. Several separate procedures in the lower and upper abdomen are necessary for complete cytoreduction (Phillips et al., 2018). Considering the continuity of the peritoneum, these procedures could potentially take the form of an en-block specimen (Kalra et al., 2021). This approach is technically quite challenging and needs excellent understanding of the anatomy. Our aim is to present the feasibility of removing one en-block specimen, composed of multiple excisions and to propose an intraoperative strategy on how to perform such a dissection. This video demonstrates an en-block primary cytoreduction in a 62-year-old patient with stage IIIC ovarian cancer (FIGO) who underwent laparotomy, right diaphragmatic stripping, Morrison's pouch and right abdominal peritonectomy, radical omentectomy, splenectomy and modified posterior exenteration with end-to-end rectosigmoid anastomosis. End result was complete cytoreduction and final histology showed high grade serous carcinoma. The postoperative period was uneventful, and the patient was discharged on day 6. She completed 6 cycles of carboplatin and paclitaxel chemotherapy and is free of disease 32 months later. In conclusion, this approach follows the dissemination pattern of ovarian cancer and allows for a better understanding of the anatomy of the peritoneum. We propose that en-block excisions might be particularly useful for the training of young Gynaecological Oncologists in order to enhance their knowledge of the anatomy and their surgical skills.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120354 | PMC |
http://dx.doi.org/10.1016/j.gore.2023.101170 | DOI Listing |
Front Oncol
January 2025
Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Introduction: Primary cilia play an important role in the development of cancer by regulating signaling pathways. Several studies have demonstrated that women with mutations have, on average, 50% fewer ciliated cells compared with general women. However, the role of tubal cilia loss in the development of epithelial ovarian cancer (EOC) remains unclear.
View Article and Find Full Text PDFCureus
December 2024
Pulmonary and Critical Care Medicine, Community Health Network, Indianapolis, USA.
Pleural effusion as an initial presentation of malignancy poses significant diagnostic challenges, particularly when linked to gynecologic cancers. We discuss the case of a 53-year-old female who presented with progressive dyspnea and a massive right-sided pleural effusion. Cytological analysis of the pleural fluid revealed malignant cells and immunohistochemical staining confirmed high-grade serous carcinoma (HGSC) of ovarian origin.
View Article and Find Full Text PDFFront Med (Lausanne)
January 2025
Department of Surgery, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.
Opsoclonus-myoclonus syndrome (OMS) is a rare neurological inflammatory disease of paraneoplastic, parainfectious or idiopathic origin. It is manifested by the occurrence of opsoclonus, myoclonus, ataxia, as well as behavioral and sleep disorders. The incidence is estimated at 1/5,000,000 people.
View Article and Find Full Text PDFBMC Womens Health
January 2025
School of Nursing and Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Background: Ovarian cancer is a leading cause of mortality worldwide. The third most prevalent gynecological cancer globally, following cervical and uterine cancer, and the third leading cause of cancer-related mortality among women in Sub-Saharan Africa, including Ethiopia. The time ovarian cancer patients have to wait between diagnosis and initiation of treatment are the indicators of quality in cancer care and influence patient outcomes.
View Article and Find Full Text PDFBMC Cancer
January 2025
Molecular Diseases & Diagnostics Division, Infinity Biochemistry, Infinity Solutions Unlimited, Sajjad Abad, Chattabal, Srinagar, 190010, Kashmir, India.
Background: Gynecological cancers (GCs) affect the reproductive system of females, and are of multiple types depending on the affected organ most common of which are cervical, endometrial, ovarian cancers. Among different risk factors for GCs, ABO blood group system is considered as one of the pivotal contributing factors for increased susceptibility of GCs. The aim of our study was to report on the demographics of GC patients and to investigate the relationship between the ABO blood group system and the risk of acquiring GC in our population.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!